All In MedTech

FDA Clearance Tracker · P030036

MEDTRONIC SELECTSECURE LEAD MODEL 3830

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Aug 3, 2005 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Aug 3, 2005

Approved

Time to decision

699 days

Received Sep 4, 2003. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P030036
Device name
MEDTRONIC SELECTSECURE LEAD MODEL 3830
Applicant location
Mounds View, MN
Received
Sep 4, 2003
Decided
Aug 3, 2005
Decision
Approved
Supplements
159 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code NVN

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE SELECTSECURE LEAD MODEL 3830. THE MODEL 3830 LEAD HAS APPLICATIONS WHERE IMPLANTABLE ATRIAL OR VENTRICULAR, SINGLE-CHAMBER OR DUAL-CHAMBER PACING SYSTEMS ARE INDICATED. THE MODEL 3830 LEAD IS INTENDED FOR PACING AND SENSING IN THE ATRIUM OR VENTRICLE.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code NVN. The earliest in FDA's data is P850089, decided Jul 29, 1986.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Medtronic Cardiac Rhythm Disease Management

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.